ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,220 | -41.7% | 2,000 | -20.0% | 0.00% | -50.0% |
| Q2 2023 | $8,950 | +36.9% | 2,500 | -16.7% | 0.00% | 0.0% |
| Q1 2023 | $6,540 | -81.9% | 3,000 | 0.0% | 0.00% | -77.8% |
| Q4 2022 | $36,090 | +89.9% | 3,000 | 0.0% | 0.01% | +80.0% |
| Q3 2022 | $19,000 | +35.7% | 3,000 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $14,000 | -46.2% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $26,000 | -39.5% | 3,000 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $43,000 | -34.8% | 3,000 | 0.0% | 0.01% | -40.0% |
| Q3 2021 | $66,000 | +22.2% | 3,000 | -25.0% | 0.02% | +25.0% |
| Q2 2021 | $54,000 | – | 4,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 8,355 | $61,000 | 0.04% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 70,000 | $508,000 | 0.01% |
| Financial Architects, Inc | 2,000 | $15,000 | 0.00% |
| FineMark National Bank & Trust | 3,473 | $25,000 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 1,000 | $7,000 | 0.00% |
| Penserra Capital Management LLC | 2,540 | $18,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,284 | $10,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,673 | $19,000 | 0.00% |
| Plante Moran Financial Advisors, LLC | 300 | $2,000 | 0.00% |
| Cutler Group LLC / CA | 2,404 | $17,000 | 0.00% |